. Author manuscript; available in PMC: 2016 Apr 22.

Published in final edited form as: J Urol. 2015 Jul 17;195(1):74–79. doi: 10.1016/j.juro.2015.07.078

Table 1.

Patient characteristics.

	N=392
Baseline or initial biopsy results
Median (IQR) age (years)	62 (56–66)
No. clinical stage (%)
T1	348 (89%)
T2	44 (11%)
Median (IQR) PSA (ng/ml)	4.5 (3.4–5.9)
Median (IQR) PSA density (ng/ml/cm³)	0.10 (0.07–0.14)
Median (IQR) total number of biopsy cores	12 (12–13)
Median (IQR) percent positive cores from all cores (%)	8.3 (8.3–16.7)
Median (IQR) total tumor length from all positive cores (mm)	1.5 (0.7–3.5)
Median (IQR) percent cancer from all positive cores (%)	10.0 (5.0–20.0)
*MRI result, no. (%)**
No dominant/focal tumor	208 (53)
Dominant/focal tumor	184 (47)
Confirmatory biopsy result
No. Gleason score (%)
No cancer on biopsy	135 (34)
6	213 (54)
3+4	39 (10)
4+3	1 (0.3)
8	3 (0.8)
9	1 (0.3)